See more : Bridge SaaS Limited (BGE.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Guanhao Biotech Co.,Ltd. (300238.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guanhao Biotech Co.,Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- PT Sidomulyo Selaras Tbk (SDMU.JK) Income Statement Analysis – Financial Results
- GoviEx Uranium Inc. (GVXXF) Income Statement Analysis – Financial Results
- HILIKS TECHNOLOGIES LIMITED (HILIKS.BO) Income Statement Analysis – Financial Results
- Mitsui Chemicals, Inc. (MITUY) Income Statement Analysis – Financial Results
- Mingchen Health Co.,Ltd. (002919.SZ) Income Statement Analysis – Financial Results
Guanhao Biotech Co.,Ltd. (300238.SZ)
About Guanhao Biotech Co.,Ltd.
Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 404.18M | 377.29M | 488.98M | 436.96M | 437.89M | 458.46M | 450.37M | 312.79M | 226.17M | 190.36M | 168.50M | 147.02M | 128.51M | 102.62M | 65.57M | 35.19M | 22.38M |
| Cost of Revenue | 84.37M | 89.62M | 121.69M | 120.04M | 141.44M | 125.96M | 120.41M | 68.41M | 40.90M | 22.12M | 16.96M | 10.41M | 7.89M | 7.29M | 3.91M | 1.96M | 1.41M |
| Gross Profit | 319.81M | 287.66M | 367.29M | 316.92M | 296.44M | 332.50M | 329.96M | 244.38M | 185.27M | 168.24M | 151.54M | 136.61M | 120.62M | 95.33M | 61.66M | 33.23M | 20.97M |
| Gross Profit Ratio | 79.13% | 76.25% | 75.11% | 72.53% | 67.70% | 72.52% | 73.26% | 78.13% | 81.92% | 88.38% | 89.93% | 92.92% | 93.86% | 92.90% | 94.04% | 94.42% | 93.71% |
| Research & Development | 44.50M | 50.52M | 46.62M | 34.25M | 69.95M | 42.96M | 19.19M | 13.05M | 17.32M | 25.59M | 24.69M | 14.85M | 16.09M | 17.69M | 24.64M | 13.49M | 0.00 |
| General & Administrative | 21.67M | 21.17M | 15.78M | 15.65M | 63.65M | 20.76M | 32.12M | 30.73M | 17.14M | 15.45M | 13.75M | 11.87M | 9.64M | 4.33M | 3.69M | 2.74M | 9.01M |
| Selling & Marketing | 108.04M | 156.40M | 185.21M | 180.98M | 185.58M | 184.24M | 170.61M | 109.34M | 67.63M | 60.12M | 61.71M | 69.83M | 46.89M | 30.08M | 17.18M | 8.70M | 8.87M |
| SG&A | 228.62M | 177.57M | 200.99M | 196.63M | 249.23M | 204.99M | 202.72M | 140.07M | 84.77M | 75.57M | 75.45M | 81.69M | 56.53M | 34.41M | 20.87M | 11.44M | 17.88M |
| Other Expenses | 8.81M | -541.64K | 498.80K | -88.04K | 1.98M | 8.63M | 6.06M | 18.60M | 12.66M | 8.61M | 8.00M | 8.39M | 6.89M | 3.73M | 4.20M | 3.18M | 380.00K |
| Operating Expenses | 285.82M | 238.43M | 264.45M | 248.62M | 337.69M | 268.38M | 235.16M | 185.02M | 124.42M | 123.02M | 118.30M | 111.29M | 82.83M | 60.78M | 50.85M | 28.63M | 17.88M |
| Cost & Expenses | 370.19M | 328.05M | 386.14M | 368.67M | 479.13M | 394.34M | 355.57M | 253.44M | 165.32M | 145.13M | 135.27M | 121.70M | 90.73M | 68.07M | 54.76M | 30.59M | 19.29M |
| Interest Income | 1.50M | 2.22M | 2.19M | 3.22M | 891.06K | 2.58M | 4.44M | 4.23M | 5.91M | 6.65M | 6.02M | 7.80M | 1.61M | 254.12K | 141.13K | 140.06K | -0.74 |
| Interest Expense | 1.78M | 4.11M | 7.36M | 14.58M | 15.78M | 22.80M | 10.60M | 6.98M | 972.43K | 6.90M | 41.48K | 39.03K | 43.36K | 29.73K | -17.16K | 147.06K | 23.10K |
| Depreciation & Amortization | 29.01M | 41.14M | 49.83M | 35.01M | 42.66M | 37.30M | 34.58M | 28.45M | 22.08M | 17.79M | 11.92M | 8.43M | 4.29M | 4.50M | 3.00M | 1.50M | -82.82K |
| EBITDA | 62.88M | -234.75M | 146.15M | 97.72M | -418.59M | 116.51M | 112.32M | 93.15M | 101.65M | 62.92M | 48.65M | 33.75M | 42.08M | 40.15M | 17.11M | 8.99M | 3.03M |
| EBITDA Ratio | 15.56% | 18.37% | 28.22% | 22.44% | -4.92% | 23.60% | 25.63% | 30.73% | 43.63% | 33.27% | 27.32% | 22.90% | 33.06% | 41.18% | 27.70% | 27.25% | 13.56% |
| Operating Income | 33.99M | -292.04M | 81.56M | 44.96M | -486.86M | 43.44M | 67.13M | 42.30M | 61.67M | 51.10M | 38.40M | 33.17M | 38.95M | 33.91M | 10.89M | 4.67M | 3.12M |
| Operating Income Ratio | 8.41% | -77.41% | 16.68% | 10.29% | -111.18% | 9.48% | 14.90% | 13.52% | 27.27% | 26.84% | 22.79% | 22.56% | 30.31% | 33.05% | 16.61% | 13.26% | 13.93% |
| Total Other Income/Expenses | -1.90M | -541.63K | 498.80K | -88.04K | 1.98M | 8.63M | 5.41M | 18.99M | 12.54M | 8.39M | 7.97M | 8.38M | 6.89M | 3.73M | 4.20M | 3.18M | 380.00K |
| Income Before Tax | 32.09M | -292.58M | 82.06M | 44.88M | -484.88M | 52.07M | 73.19M | 61.29M | 74.21M | 59.49M | 46.37M | 41.56M | 45.83M | 37.64M | 15.09M | 7.84M | 3.50M |
| Income Before Tax Ratio | 7.94% | -77.55% | 16.78% | 10.27% | -110.73% | 11.36% | 16.25% | 19.59% | 32.81% | 31.25% | 27.52% | 28.26% | 35.67% | 36.68% | 23.01% | 22.29% | 15.63% |
| Income Tax Expense | 11.02M | 35.08M | 31.32M | 3.52M | 5.87M | 16.95M | 25.47M | 12.99M | 11.74M | 9.39M | 5.80M | 4.52M | 5.41M | 5.29M | 669.52K | 749.16K | 686.92K |
| Net Income | 31.01M | -307.84M | 73.69M | 46.59M | -465.33M | 45.75M | 57.48M | 56.96M | 63.37M | 50.10M | 40.57M | 37.03M | 40.42M | 32.34M | 14.42M | 7.09M | 2.81M |
| Net Income Ratio | 7.67% | -81.59% | 15.07% | 10.66% | -106.27% | 9.98% | 12.76% | 18.21% | 28.02% | 26.32% | 24.08% | 25.19% | 31.45% | 31.52% | 21.99% | 20.16% | 12.56% |
| EPS | 0.12 | -1.16 | 0.28 | 0.18 | -1.75 | 0.17 | 0.17 | 0.23 | 0.26 | 0.20 | 0.17 | 0.15 | 0.17 | 0.19 | 0.10 | 0.06 | 0.07 |
| EPS Diluted | 0.12 | -1.16 | 0.28 | 0.18 | -1.75 | 0.17 | 0.17 | 0.23 | 0.26 | 0.20 | 0.17 | 0.15 | 0.17 | 0.19 | 0.10 | 0.06 | 0.07 |
| Weighted Avg Shares Out | 258.38M | 265.16M | 265.16M | 265.16M | 265.16M | 265.16M | 265.16M | 247.63M | 243.72M | 250.52M | 245.90M | 246.88M | 244.98M | 174.82M | 147.87M | 123.39M | 41.63M |
| Weighted Avg Shares Out (Dil) | 258.38M | 265.16M | 265.16M | 265.16M | 265.16M | 269.10M | 267.78M | 247.63M | 243.72M | 250.52M | 245.90M | 246.88M | 244.98M | 174.82M | 147.87M | 123.39M | 41.63M |
Source: https://incomestatements.info
Category: Stock Reports